Cultivo Land PBC
We are focused on developing leronlimab, a monoclonal antibody C - C chemokine receptor type 5 (“CCR5”) receptor antagonist, to be used as a platform drug for a variety of indications. The target of leronlimab is the immunologic receptor CCR5. The CCR5 receptor is a protein located on the surface of a variety of cells including white blood cells and cancer cells.
DMG Buffalo Student Income Feeder LP
DMG Buffalo Student Income Master LP
Darrell Schmidt Enterprises Inc
Deloitte & Touche LLP
Deloitte Consulting LLP
Deloitte Financial Advisory Services LLP
Deloitte Tax LLP
Deloitte Touche Tohmatsu Services, Inc.
Deutsche DWS Money Market Trust
Deutsche DWS Municipal Trust
Deutsche DWS Tax Free Trust
Dixon Hughes Goodman Wealth Advisors LLC
Dos Mil Doscientos Uno, S.L.
Drake Petroleum Company, Inc.
Dreyfus Intermediate Municipal Bond Fund Inc
Dreyfus New York Tax Exempt Bond Fund Inc